Skip to content

A study on the application of automatic three-dimensional ultrasound volume measurement technique in the sclerotherapy of multiple organ cysts

A study on the application of automatic three-dimensional ultrasound volume measurement technique in the sclerotherapy of multiple organ cysts

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090882
Enrollment
Unknown
Registered
2024-10-15
Start date
2023-10-09
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiorgan Cyst

Interventions

Estimation of hardener use (V1) group based on 2D ultrasonic ellipsoid volume equation method:Prior to cystosclerosis treatment, two physicians with more than 5 years of independent diagnostic ultraso
Estimation of hardener use (V2) group based on 3D ultrasound Vocal method:Prior to cystosclerosis treatment, two physicians with more than 5 years of independent diagnostic ultrasound experience measu
The amount of sclerosing agent used was determined according to the actual amount of fluid withdrawn from the patients cyst (Group V3):During cyst sclerotherapy, the cystic fluid was completely withdr

Sponsors

Wuxi Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with abdominal cysts who meet the indications for ultrasound-guided cyst sclerotherapy, including: cysts =5 cm in diameter or symptomatic; cysts with combined bleeding or infection, and those with a percutaneous puncture pathway.

Exclusion criteria

Exclusion criteria: 1. there is a large amount of sediment in the cystic cavity or intraoperative bleeding, 2. the cysts are separated by >3, 3. three-dimensional ultrasound cannot completely show the cystic cavity, 4. the cystic fluid is not extracted during the operation, 5. the cystic cavity is judged to be in communication with the surrounding tubular lumen during the process of extracting the fluid, and it is not possible to carry out the sclerotherapy, 6. there is abnormality in the coagulation function, and 7. the patient is not able to tolerate the treatment, and the patient has not completed the treatment.

Design outcomes

Primary

MeasureTime frame
Cyst volume;cystic fluid volume;

Countries

China

Contacts

Public ContactHuang Lie Cheng

Wuxi Traditional Chinese Medicine Hospital

huangliecheng1988@126.com+86 151 0619 5559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026